AMETEK INC/
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $AME in the last 30 days.
See all $AME insider activity →AMETEK (AME) completed a $5.0B cash acquisition of Indicor Instrumentation. The company reported record Q2 sales of $2.04B, up 15% YoY, and raised full-year guidance. Indicor is expected to add $350M to 2026 sales and be modestly accretive to earnings. The deal aligns with AMETEK's existing portfolio and markets.
BNP Paribas Exane raised Ametek's (NYSE:AME) price target to $290, citing the Indicor deal and projecting $10.60 EPS by 2028. Ametek reported Q2 2026 earnings of $2.09 per share on $2.04B revenue, beating estimates. The company also increased its commercial paper program limit to $3.5B.
AMETEK (AME) reported Q2 2026 earnings with revenue up 15% to $2.04b, beating expectations. Despite a recent share price decline, long-term returns remain strong. The company raised its outlook, but valuation is debated, with some analysts suggesting undervaluation while others question growth expectations.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning AME (AMETEK INC/). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent AME coverage spans earnings, mergers & acquisitions and financial news.
The deal expands AMETEK's product portfolio and adds $350 M to 2026 sales, likely boosting earnings per share after integration.
Target raise suggests ~20% upside, likely prompting buying interest.
Earnings beat and higher outlook may lift the stock despite recent pullback.
Potential upside as analysts increase target price, may attract buying interest.
Significant expansion of Ametek’s instrumentation business.
AlphAI scores every news story that mentions AME with an AI model for sentiment and relevance, and aggregates insider trades from AMETEK INC/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
AMETEK (AME) completed a $5.0B cash acquisition of Indicor Instrumentation. The company reported record Q2 sales of $2.04B, up 15% YoY, and raised full-year guidance. Indicor is expected to add $350M to 2026 sales and be modestly accretive to earnings. The deal aligns with AMETEK's existing portfolio and markets.
2 min readBNP Paribas Exane raised Ametek's (NYSE:AME) price target to $290, citing the Indicor deal and projecting $10.60 EPS by 2028. Ametek reported Q2 2026 earnings of $2.09 per share on $2.04B revenue, beating estimates. The company also increased its commercial paper program limit to $3.5B.
2 min readAMETEK (AME) reported Q2 2026 earnings with revenue up 15% to $2.04b, beating expectations. Despite a recent share price decline, long-term returns remain strong. The company raised its outlook, but valuation is debated, with some analysts suggesting undervaluation while others question growth expectations.
2 min readSeaport Global raised its price target for AMETEK to $300 from $290, maintaining a buy rating. The company's stock is currently trading at $233.19, up 0.81% on the day but down 4.90% over the past year. AMETEK recently completed the acquisition of Indicor Instrumentation.
1 min readCarets Corp is exploring a potential sale, including its technology and patents. Algorhythm Holdings (RIME) and Biomerica (BMRA) are evaluating strategic alternatives. nVent Electric (NVT) acquired Maverick Power for $1.75B, with up to $550M more in performance-based payments. Descartes (DSGX) bought Tai for $100M, and Navitas (NVTS) acquired Claros for up to $232.8M. Booz Allen (BAH) completed a $720M acquisition, and Elastic (ESTC) acquired Deductive AI. BioXcel (BTAI) filed for Chapter 11 ban
3 min readAMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.
2 min readAmetek (AME) was upgraded to a Zacks Rank #2 (Buy) due to upward trends in earnings estimates, which are a key driver of stock prices. The upgrade reflects positivity about the company's earnings outlook, potentially leading to increased buying pressure and stock price appreciation. The Zacks rating system is based on changing earnings estimates, which have shown a strong correlation with near-term stock movements.
2 min readAMETEK (NYSE: AME) raised its 2026 outlook after Q2 results. Second-quarter adjusted earnings rose 17% to $2.09 per diluted share, with sales up 15% to $2.04 billion and orders up 28%. AMETEK now expects 2026 adjusted earnings of $8.20 to $8.30 per share and sales up about 10% from 2025.
4 min readThe article says 21 analysts cover AMETEK (AME) and the consensus is a “Moderate Buy,” with 13 “Strong Buy,” one “Moderate Buy,” and seven “Hold” ratings. It notes ratings have been stable over three months. TD Cowen reiterated a “Buy” on Aug. 6 and raised its price target to $275, implying 6.4% upside, while the street-high target is $316.
2 min readStanage Nick L purchased 4,000 shares of AMETEK INC/ (AME) at $255.85 ($1.02M total) on 2026-08-11.
2 min read
